Ovarian Tissue Transplantation Using Autologous Platelet-Rich Plasma: A Pilot Clinical Trial | Synapse
March 3, 2026Open Access
Ovarian Tissue Transplantation Using Autologous Platelet-Rich Plasma: A Pilot Clinical Trial
Key Points
Restoration of ovarian function may be enhanced with the addition of autologous PRP.
The pilot trial confirms the feasibility and safety of this adjunct intervention in ovarian tissue transplantation.
Assessment involved the use of autologous platelet-rich plasma during the transplantation procedure.
Further studies are needed to explore long-term impacts and efficacy in larger populations.
Abstract
Autologous PRP appears to be a feasible and safe adjunct in orthotopic ovarian tissue transplantation, potentially enhancing the restoration of ovarian function.